View profile

THCB Reader - Issue #4

Revue
 
Every two weeks THCB reader gives you a flavor of the great stuff on The Health Care Blog. In this ed
 

THCB Reader

April 4 · Issue #4 · View online
Everything you always wanted to know about the health care system. But were afraid to ask.

Every two weeks THCB reader gives you a flavor of the great stuff on The Health Care Blog. In this edition, Mike Magee beats up on billionaires who don’t understand how large scale reform health care will save money;  Phouc Le & Sam Aptekar address the inadequate care given to Native Americans; and Bishal Gyawali gives us a quick review of what’s going on in Oncology. In video Jess DaMassa has Bayer’s digital guru Eugene Borukhovich dishing on digital therapeutics, while Health in 2 Point 00 catches you up with the latest health tech news and April Fools. Enjoy!—Matthew Holt  


March 29, Phuoc Le and Sam Aptekar
American Indians and Alaska Natives represent the only populations in the United States with a legal birthright to health care. In the wake of the 36-year anniversary of seminal case United States v. Mitchell, which established this principle as a matter of law, we must take note of the federal government’s failure to adequately fund the healthcare institutions that serve American Indians and Alaska Natives despite its legal responsibility to do so.
March 28, Mike Magee
Within the ever-widening array of Democratic contenders for the Presidency, the “Medicare for All” debate continues to simmer. What gets overlooked, however, is that large-scale health reform’s potential savings could be put towards other systemic problems. We could have the courage and the will to reapply our more than ample health care assets and reject the status quo. We could elect leaders willing to honestly address a simple, long overdue question: “How do we make Americans healthy?”
March 26, Bishal Gyawali
What’s been going on in the world of oncology so far? Dr. Bishal Gyawali gives us a rundown of the major news, featuring the LION trial, which showed that lymph node dissection doesn’t improve survival in patients with advanced ovarian cancer, and a series of methodological issues in articles published in top journals—including one trial with what may be the most difficult drug to pronounce/spell in oncology, sacituzumabgovitecan-hziy.

For more information visit www.livongo.com
Health in 2 Point 00, Episode 76 | Facebook releasing an EMR? Jim Cramer Going to Epic? #AprilFools
Health in 2 Point 00, Episode 76 | Facebook releasing an EMR? Jim Cramer Going to Epic? #AprilFools
For more information visit https://www.americantelemed.org/
Will Digital Therapeutics be ‘The End’ of Digital Health? | Eugene Borukhovich, G4A Bayer
Will Digital Therapeutics be 'The End' of Digital Health? | Eugene Borukhovich, G4A Bayer
We hope you enjoyed the pieces and videos we had for you today. As always, if you have a piece you would like us to consider, please email zoyakhan@smack.health and if you are looking to reach 20K of the smartest people in health care on this newsletter, or 80-100K each month on the site, please think of sending some of your marketing $$$ our way! Here’s our prospectus.

Best Wishes,
Did you enjoy this issue?
If you don't want these updates anymore, please unsubscribe here
If you were forwarded this newsletter and you like it, you can subscribe here
Powered by Revue
120 Humboldt Avenue, San Anselmo, CA 94960